Description
Recombinant Rubella Virus-like Particles (RuV VLPs) are produced in mammalian HEK293 cells, assembled with Spike glycoprotein E1, Spike glycoprotein E2 and Capsid protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. RuV VLPs can be used in the development of RuV diagnostics and in vaccine development and R&D (including use as an immunogen).